Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Astemizole

A long-acting second-generation antihistamine, discovered in Belgium in 1977 and used for allergy symptoms such as itching and swelling; it was withdrawn from the market worldwide in 1999. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.

Did you know?After its withdrawal it kept attracting researchers: it has been studied against Creutzfeldt-Jakob disease, caused by prions, and for its binding to proteins linked to Alzheimer's disease.

AstemizoleGo to the active ingredient →
AstemizoleActive ingredientAstemizoleCat. No. P-A202-001CAS 68844-77-9
Astemizole-d3Isotopically labelledAstemizole-d3Cat. No. P-A202-003CAS 1189961-39-4

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.